Automyelotransfusion in radiation therapay of Hodgkin's disease

Buachidze, L N; Vygodskaya, A.L.; Kaverzneva, M.M.; Kazakova, S.Y.; Lorie, Yu.I.; Yarmonenko, S.P.

doi:10.1016/0360-3016(77)90004-9

International Journal of Radiation Oncology*Biology*Physics

1977

DOI: 10.1016/0360-3016(77)90004-9

|View full text |Cite

Automyelotransfusion in radiation therapay of Hodgkin's disease

L N Buachidze¹,

A.L. Vygodskaya²,

M.M. Kaverzneva³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1977

1986

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent data by Buachidze using autologous bone marrow transplantation in patients receiving total nodal irradiation for Hodgkin's disease have been presented (31). An initial acute benefit was shown for patients who received bone marrow transplantation in both platelet and granulocyte counts during and shortly following irradiation.…”

mentioning

confidence: 99%

Radiation and chemical injury in the bone marrow.

Dritschilo¹,

Sherman²

1981

Environ Health Perspect

View full text Add to dashboard Cite

Hematopoietic system toxicity is a major limiting factor in the use of aggressive combined modality therapy in the treatment of malignant disease. In this review, the known drug-x-ray interactions using tissue culture systems are extended to the bone marrow compartment. Two hypotheses prevail for late bone marrow failure: (1) stromal damage to the vasculature with subsequent fibrosis and (2) irreversible stem cell depletion in the irradiated site. Clinical extensions of the experimental data for bone marrow kinetics in the animal model have not proven successful to date. The future strategies for therapy of malignancies in which both radiation and chemotherapy are employed may require dose modification or treatment planning to limit bone marrow toxicity.

show abstract

mentioning

confidence: 99%

Radiation and chemical injury in the bone marrow.

Dritschilo¹,

Sherman²

1981

Environ Health Perspect

View full text Add to dashboard Cite

show abstract

Bone marrow autografting

Rubin

1977

International Journal of Radiation Oncology*Biology*Physics

View full text Add to dashboard Cite

The bone marrow organ: The critical structure in radiation-drug interaction

Rubin¹,

Scarantino²

1978

International Journal of Radiation Oncology*Biology*Physics

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Automyelotransfusion in radiation therapay of Hodgkin's disease

Cited by 6 publications

References 8 publications

Radiation and chemical injury in the bone marrow.

Radiation and chemical injury in the bone marrow.

Bone marrow autografting

The bone marrow organ: The critical structure in radiation-drug interaction

Contact Info

Product

Resources

About